CCCC

C4 Therapeutics, Inc

1 day chart

About CCCC

C4 Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on advancing targeted protein degradation science to develop a new generation of small-molecule medicines to transform how disease is treated. It leverages its technology platform, Target ORiented ProtEin Degrader Optimizer (TORPEDO), to design and optimize small-molecule medicines that harness the body's natural protein recycling system to rapidly degrade disease-causing proteins. Its TORPEDO platform enables the discovery of targeted investigational small molecule medicines called protein degraders. Its advanced product candidate, CFT7455, is an orally bioavailable MonoDAC degrader of protein targets called IKZF1 and IKZF3, which are in clinical development for multiple myeloma (MM), and non-Hodgkin lymphomas (NHLs). Its other product candidate, CFT8634, is an orally bioavailable BiDAC degrader of a protein target called BRD9 for the treatment of synovial sarcoma and SMARCB1-null solid tumors.

Buy US stocks in Australia starting with CCCC. Open an account and start investing today!

Market Capitalisation

$77.23M

Price-earnings ratio

Dividend yield

0.00%

Volume

182.08K

High today

$1.69

Low today

$1.51

Open price

$1.61

52-week high

$9.41

52-week low

$1.23

CCCC FAQs

Can I buy CCCC shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?

Yes, the Stake platform allows you to buy CCCC shares and over 8,000 stocks and ETFs across the ASX and Wall St.

How much is one share of C4 Therapeutics, Inc?

One share of C4 Therapeutics, Inc is valued at $1.52.

What is the ticker symbol for C4 Therapeutics, Inc?

The ticker symbol for C4 Therapeutics, Inc is CCCC.

How do I buy CCCC shares in Australia?

To buy CCCC stocks in Australia you'll need to open an account with an investing platform like Stake.
To do so follow these steps:

Sign up in minutes, all you need is some I.D.
Choose Stake Wall St
Deposit directly into your Stake wallet and you're ready to invest in CCCC

What is the 52-week high for C4 Therapeutics, Inc stock?

The C4 Therapeutics, Inc 52-week high stock price is $9.41.

What is the 52-week low for C4 Therapeutics, Inc stock?

The C4 Therapeutics, Inc 52-week low stock price is $1.23.

What is the market capitalisation of C4 Therapeutics, Inc CCCC?

As of 30/11/2023 C4 Therapeutics, Inc has a market cap of $77M.

Related Stocks

This does not constitute financial advice. You should do your own research before making an investment decision. Past performance is not a reliable indication of future performance. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.